PROCEPT BioRobotics (PRCT) Capital Expenditures Growth (1y) (2021 - 2026)
Analysis
PROCEPT BioRobotics (PRCT) Capital Expenditures Growth (1y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.01 Bn | 172.41 Bn | 7.27 Bn | -1.00% |
| 2 | Intuitive Surgical | 131.29 Bn | 126.08 Bn | 1.96 Bn | -27.50% |
| 3 | Medtronic | 116.38 Bn | 107.56 Bn | 6.34 Bn | -0.20% |
| 4 | Stryker | 106.01 Bn | 102.53 Bn | 4.50 Bn | 10.38% |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | 24.20% |
| 6 | Edwards Lifesciences | 48.89 Bn | 44.64 Bn | 1.35 Bn | 35.70% |
| 7 | Alcon | 32.59 Bn | 31.13 Bn | 1.68 Bn | 5.88% |
| 8 | Dexcom | 31.84 Bn | 29.89 Bn | 830.00 Mn | -9.99% |
| 9 | Steris | 20.61 Bn | 20.13 Bn | 684.20 Mn | -6.52% |
| 10 | PROCEPT BioRobotics | 1.17 Bn | 895.36 Mn | 62.38 Mn | 5.39% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.39% |
| Mar 31, 2026 | 58.71% |
| Dec 31, 2025 | 57.58% |
| Sep 30, 2025 | 1,065.85% |
| Jun 30, 2025 | 168.65% |
| Mar 31, 2025 | -5.65% |
| Dec 31, 2024 | -86.53% |
| Sep 30, 2024 | -95.74% |
| Jun 30, 2024 | -80.58% |
| Mar 31, 2024 | -63.55% |
| Dec 31, 2023 | 396.02% |
| Sep 30, 2023 | 373.38% |
| Jun 30, 2023 | 2,398.60% |
| Mar 31, 2023 | 1,421.08% |
| Dec 31, 2022 | 429.22% |
| Sep 30, 2022 | 3,491.18% |
| Jun 30, 2022 | 726.92% |
| Mar 31, 2022 | 75.50% |
| Dec 31, 2021 | 3,588.89% |